DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Dow Jones - 19 Johnson - 2 Mark Kauzlarich - 1 Jennifer Taubert - 1 Joseph Wolk - 1 Ashley McEvoy - 1 WSJ’s Daniela Hernandez - 1 Elizabeth Smelov - 1
Top related locs:
U.S San Francisco Elizabeth Smelov U.S Novo Philadelphia Lansdale Pa
Top related orgs:
Bloomberg - 1 Johnson - 1 Novo Nordisk - 1 johnson - 1 Wall Street - 1 Harvard Business Review Press - 1 Reporter - 1 University of Notre Dame - 1

Search resuls for: "Peter Loftus"


25 mentions found


☆ The Executives Who Could Be Johnson & Johnson’s Next CEO
  + stars: | 2023-12-04 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
J&J is one of the best-known healthcare companies in the world, with more than 130,000 employees. Photo: Mark Kauzlarich/Bloomberg NewsThe succession race is on at Johnson & Johnson , after the abrupt departure of a top executive widely believed to have been in line for the healthcare company’s top job. Jennifer Taubert , a no-nonsense veteran who runs J&J’s pharmaceuticals business, and the investor-minded Chief Financial Officer Joseph Wolk are leading contenders for the top job after the surprising exit of J&J’s medical-device head Ashley McEvoy in October, people familiar with the succession race said.
Persons: Mark Kauzlarich, Johnson, Jennifer Taubert, Joseph Wolk, Ashley McEvoy Organizations: Bloomberg, Johnson
☆ J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?
  + stars: | 2023-11-30 | by ( Peter Loftus | Photographs Michael Bucher The Wall Street Journal | ) www.wsj.com   time to read: 1 min
Johnson & Johnson is making one of the biggest bets in the healthcare industry on using data science and artificial intelligence to bolster its work. The 137-year-old pharmaceutical and medical-device company has hired 6,000 data scientists and digital specialists in recent years, and spent hundreds of millions of dollars on their work, such as using machines to scour massive health-record datasets. Last year the company opened a state-of-the-art research site near San Francisco that houses advanced data science.
Persons: Johnson Locations: San Francisco
☆ Same Drug, Two Prices: Why the Higher Price Prevails
  + stars: | 2023-11-08 | by ( Peter Loftus | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
The way medicines are paid for in the U.S. has become so convoluted that some drugmakers are setting two prices for the same drug—and many health plans are choosing to cover the more expensive version. The decisions mean some patients are paying hundreds of dollars more in out-of-pocket charges to fill a prescription for an identical medicine made by the same company.
Locations: U.S
☆ Same Drug, Two Prices: Why The Higher Price Prevails
  + stars: | 2023-11-08 | by ( Peter Loftus | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
The way medicines are paid for in the U.S. has become so convoluted that some drugmakers are setting two prices for the same drug—and many health plans are choosing to cover the more expensive version. The decisions mean some patients are paying hundreds of dollars more in out-of-pocket charges to fill a prescription for an identical medicine made by the same company.
Locations: U.S
☆ Eli Lilly’s Mounjaro Approved for Weight Loss in the U.S.
  + stars: | 2023-11-08 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
Earlier: Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over unintended consequences. Illustration: Elizabeth SmelovU.S. drug regulators have approved expanding the use of Eli Lilly ’s diabetes drug Mounjaro to include the treatment of obesity. The Food and Drug Administration’s decision Wednesday furthers the rapid rise of Mounjaro—and similar-acting therapies Ozempic and Wegovy from Novo Nordisk —that have in a matter of months reshaped the treatment of obesity and doctors’ understanding of its roots.
Persons: WSJ’s Daniela Hernandez, Elizabeth Smelov, Eli Lilly ’, Ozempic Organizations: Novo Nordisk Locations: Elizabeth Smelov U.S, Novo
☆ New Playground, New Court, New Classroom? Thank Ozempic.
  + stars: | 2023-10-17 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/those-new-pickleball-courts-thank-ozempic-581899f3
Persons: Dow Jones
☆ Those New Pickleball Courts? Thank Ozempic.
  + stars: | 2023-10-17 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/those-new-pickleball-courts-thank-ozempic-581899f3
Persons: Dow Jones
☆ Illumina Ordered by EU to Unwind Grail Acquisition
  + stars: | 2023-10-12 | by ( Kim Mackrael | Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/business/illumina-ordered-by-eu-to-unwind-grail-acquisition-3c324912
Persons: Dow Jones
☆ Scientists Who Pioneered mRNA Vaccine Technology Win Nobel Prize in Medicine
  + stars: | 2023-10-02 | by ( Dominique Mosbergen | Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/nobel-prize-in-physiology-or-medicine-awarded-to-duo-for-covid-vaccine-development-83fc29b4
Persons: Dow Jones
☆ Contamination Is Found at Novo Nordisk Plant in U.S.
  + stars: | 2023-09-21 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/contamination-is-found-at-novo-nordisk-plant-in-u-s-92bca9bf
Persons: Dow Jones
☆ At Johnson & Johnson, a New Look but Old Hurdles
  + stars: | 2023-09-14 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/healthcare/at-johnson-johnson-a-new-look-but-old-hurdles-74f8fa47
Persons: Dow Jones, johnson Organizations: johnson
☆ Weight-Loss Drug Wegovy Also Works Against Heart Failure
  + stars: | 2023-08-25 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/weight-loss-drug-wegovy-also-works-against-heart-failure-a18364e7
Persons: Dow Jones
☆ Peter Loftus — Special Writer at The Wall Street Journal
  + stars: | 2023-08-17 | by ( Peter Loftus | ) www.wsj.com   time to read: +1 min
Peter LoftusPeter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device industries. He has written about Covid-19 vaccines, advances in cancer treatments, drug shortages and the use of mobile devices in healthcare. Peter is the author of "The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World," published in 2022 by Harvard Business Review Press. Before joining the Journal in 2013, he was a reporter for Dow Jones Newswires since 1997, covering the pharmaceutical and technology industries. He previously worked as a courthouse reporter at the Reporter newspaper in Lansdale, Pa.
Persons: Peter Loftus Peter Loftus, Peter, Dow Jones Newswires Organizations: Wall Street, Harvard Business Review Press, Reporter, University of Notre Dame Locations: Philadelphia, Lansdale, Pa
☆ Weight-Loss Drug Wegovy Will Stay Hard to Get This Year
  + stars: | 2023-08-10 | by ( Peter Loftus | Dominic Chopping | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/novo-nordisk-raises-guidance-amid-surging-demand-for-diabetes-obesity-drugs-e482eeb2
Persons: Dow Jones Organizations: nordisk
☆ Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
  + stars: | 2023-08-08 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/wegovy-weight-loss-drug-heart-attack-stroke-570f435e
Persons: Dow Jones
☆ Weight-Loss Drug Wegovy Cuts Stroke, Heart-Attack Risk by 20% in New Study
  + stars: | 2023-08-08 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/wegovy-weight-loss-drug-heart-attack-stroke-570f435e
Persons: Dow Jones
☆ Employers Cut Off Access to Weight-Loss Drugs for Workers
  + stars: | 2023-08-02 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/employers-cut-off-access-to-weight-loss-drugs-for-workers-cb277a44
Persons: Dow Jones
☆ U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
  + stars: | 2023-07-26 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/u-k-reviews-safety-of-ozempic-other-weight-loss-drugs-76952d65
Persons: Dow Jones
☆ Biogen to Cut Roughly 11% of Workforce to Focus on Big-Return Drugs
  + stars: | 2023-07-25 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/biogen-to-cut-roughly-11-of-workforce-to-focus-on-big-return-drugs-145b3f23
Persons: Dow Jones
☆ Biogen to Lay Off Roughly 11% of Workforce to Focus on Big-Return Drugs
  + stars: | 2023-07-25 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/biogen-to-cut-roughly-11-of-workforce-to-focus-on-big-return-drugs-145b3f23
Persons: Dow Jones
☆ The Drugs That Are Gaining on Ozempic
  + stars: | 2023-07-05 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/the-drugs-that-are-gaining-on-ozempic-71cdeb51
Persons: Dow Jones
☆ The Drugs That Are Gaining On Ozempic
  + stars: | 2023-06-27 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/the-drugs-that-are-gaining-on-ozempic-71cdeb51
Persons: Dow Jones
☆ No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming
  + stars: | 2023-06-25 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/no-more-shots-pill-versions-of-ozempic-like-drugs-are-coming-ca286ca2
Persons: Dow Jones
☆ After Illumina CEO’s Fall, Other Executives Are Expected to Take Hard Look at Deals
  + stars: | 2023-06-12 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/after-illumina-ceos-fall-other-executives-are-expected-to-take-hard-look-at-deals-c95c9e8
Persons: Dow Jones
☆ Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight
  + stars: | 2023-06-11 | by ( Peter Loftus | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/illumina-ceo-francis-desouza-resigns-89c38eec
Persons: Dow Jones, francis, desouza
0 next >>
Total: 25